A tragic incident has come to light following the death of Josephine Nasr, a 19-year-old law student from California, who was found deceased in her London dormitory. This unsettling event occurred on September 23, 2025, shortly after she had begun taking a GLP-1 weight-loss medication known as tirzepatide during the summer.
:max_bytes(150000):strip_icc():format(jpeg)/josephine-nasr-081226-1-3097eeca7bb34bafab4462bdae6c37d3.jpg)
Josephine was discovered unresponsive on the floor of her bathroom by college security personnel, who had been alerted when family members grew concerned during a phone conversation. Just two hours before, she had informed her family of experiencing nausea and vomiting. Alarmed by her symptoms, her family urged her to seek fresh air, and her sister even organised for a private healthcare provider to deliver intravenous fluids in case dehydration set in. However, when further attempts to contact her went unanswered, security staff were dispatched to her room.
Upon entering her accommodation, they found her collapsed, and despite the arrival of an ambulance, she was pronounced dead at the scene. Investigating officers located an empty vial of tirzepatide, the weight-loss drug implicated in her sudden demise.
An autopsy conducted by pathologist Alan Bates revealed that Josephine had a congenital heart condition called myocardial bridging, which could have exacerbated a risk for cardiac arrhythmia. This irregular heartbeat, alongside reported side effects of the medication, was determined to be the primary cause of her death. The court proceedings at East London Coroner’s Court underscored that she was otherwise healthy, yet the unique combination of her heart condition and issues caused by the drug led to her tragic fate.
Tirzepatide is known for its ability to promote weight loss but can induce side effects such as nausea and vomiting, which Josephine experienced. According to Bates, these symptoms might have resulted in hypoglycaemia, or low blood sugar, which can lead to an electrolyte imbalance. Bates concluded that her underlying heart condition significantly contributed to the fatal arrhythmia, ultimately leading to her untimely passing.
Josephine’s family, who were en route to Egypt from Los Angeles International Airport for a holiday, received the devastating news just as they prepared to board their flight. Her mother reportedly fainted upon hearing the tragic announcement. Consequently, instead of travelling abroad, they redirected their trip to London to formally identify their daughter.
Remembered fondly, Josephine was described as a spirited individual who placed others’ needs above her own. Her father, George Nasr, spoke of her love for travel and the ocean, while her mother, Lorin Mansour, emphasised her daughter’s commitment to faith and service within their Coptic community. The family articulated deep sorrow over the loss of such a caring and vibrant young woman.
In light of Josephine’s untimely death, questions surrounding the prescription and use of weight-loss medications like tirzepatide have arisen. The circumstances surrounding her case have prompted calls for more extensive discussions about the potential risks associated with such drugs, particularly for individuals who may not fit the typical profile for their use.
The heart-wrenching incident serves as a stark reminder of the importance of medical oversight and the potential impact of medication on those with underlying health conditions. Josephine’s legacy, characterised by her joy and altruism, will likely resonate with her peers and community, opening dialogues on health, safety, and the responsibility of healthcare providers. As the investigation continues, her family and friends seek to honour her memory and advocate for a heightened awareness regarding the implications of prescription medications on young adults.